FCMI

Foresite Capital Management II Portfolio holdings

AUM $29.2M
This Quarter Return
+36.67%
1 Year Return
+44.84%
3 Year Return
-66.21%
5 Year Return
-37.37%
10 Year Return
AUM
$141M
AUM Growth
Cap. Flow
+$141M
Cap. Flow %
100%
Top 10 Hldgs %
80.17%
Holding
19
New
19
Increased
Reduced
Closed
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
UAM
1
DELISTED
Universal American Corp
UAM
$27.8M 19.06% +3,000,000 New +$27.8M
OREX
2
DELISTED
Orexigen Therapeutics, Inc.
OREX
$24.3M 16.67% +4,017,666 New +$24.3M
LRMR icon
3
Larimar Therapeutics
LRMR
$310M
$15.4M 10.56% +500,166 New +$15.4M
ASPX
4
DELISTED
AUSPEX PHARMACEUTICALS INC COM STK (DE)
ASPX
$9.02M 6.17% +171,824 New +$9.02M
ALDR
5
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
$7.13M 4.88% +245,000 New +$7.13M
SCYX icon
6
SCYNEXIS
SCYX
$34.9M
$6.62M 4.53% +662,945 New +$6.62M
AERI
7
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
$6.42M 4.4% +220,067 New +$6.42M
QTNT
8
DELISTED
Quotient Limited Ordinary Shares
QTNT
$5.9M 4.04% +327,631 New +$5.9M
SAGE
9
DELISTED
Sage Therapeutics
SAGE
$5.29M 3.62% +144,569 New +$5.29M
JUNO
10
DELISTED
Juno Therapeutics, Inc.
JUNO
$4.78M 3.27% +91,575 New +$4.78M
BDSI
11
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$4.73M 3.24% +393,683 New +$4.73M
TTOO
12
DELISTED
T2 Biosystems, Inc
TTOO
$4.4M 3.01% +228,421 New +$4.4M
EPZM
13
DELISTED
Epizyme, Inc
EPZM
$3.81M 2.61% +201,806 New +$3.81M
PRQR icon
14
ProQR Therapeutics
PRQR
$237M
$3.75M 2.57% +173,067 New +$3.75M
ANAC
15
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
$3.45M 2.36% +106,849 New +$3.45M
AGRX
16
DELISTED
Agile Therapeutics, Inc
AGRX
$3.28M 2.25% +534,882 New +$3.28M
BLCM
17
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$2.42M 1.66% +105,000 New +$2.42M
RXDX
18
DELISTED
Ignyta, Inc.
RXDX
$1.88M 1.29% +275,000 New +$1.88M
SINT icon
19
SiNtx Technologies
SINT
$11.4M
$180K 0.12% +225,000 New +$180K